B. K. KULKARNI

Statistics

Publications

Citations

233

H-Index

Active since

1981

Affiliations

Millennium Engineering and Integration (United States)(Current)

Savitribai Phule Pune University

B. K. KULKARNI is an author at Millennium Engineering and Integration (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1981–2021

Publications

Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905)

Matthew O. Duffey, Tricia J. Vos, Ruth Adams et al. · Journal of Medicinal Chemistry · 2011 · 56 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Discovery and optimization of N-acyl and N-aroylpyrazolines as B-Raf kinase inhibitors

Christopher Blackburn, Matthew O. Duffey, Alexandra E. Gould et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf Inhibitors

Alexandra E. Gould, Ruth Adams, Sharmila Adhikari et al. · Journal of Medicinal Chemistry · 2011 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Synthetic application of lithiation reactions—XVI

N. S. Narasimhan, R. S. MALI, B. K. KULKARNI · Tetrahedron · 1983 · 28 citations

Natural Sciences, Chemical Engineering, Chemistry +8

A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease

S. Barret Kalindjian, Sanjay Venkatachalapathi Kadnur, Christopher A. Hewson et al. · Journal of Medicinal Chemistry · 2016 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

1–5 of 9